Free Trial
NASDAQ:ALVR

AlloVir (ALVR) Stock Price, News & Analysis

AlloVir logo
$2.79 -0.04 (-1.41%)
As of 05/23/2025

About AlloVir Stock (NASDAQ:ALVR)

Key Stats

Today's Range
$2.65
$2.87
50-Day Range
$2.79
$11.40
52-Week Range
$7.96
$24.15
Volume
119,062 shs
Average Volume
16,365 shs
Market Capitalization
$14.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.

Receive ALVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter.

ALVR Stock News Headlines

Kalaris Announces Closing of Merger with AlloVir
While others chase AI stocks, smart traders do this
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
Kalaris, AlloVir announce stockholder approval of merger
Allovir's Vikas Sinha sells shares worth $3,052
See More Headlines

ALVR Stock Analysis - Frequently Asked Questions

AlloVir's stock was trading at $9.66 at the beginning of the year. Since then, ALVR stock has decreased by 71.1% and is now trading at $2.79.
View the best growth stocks for 2025 here
.

AlloVir, Inc. (NASDAQ:ALVR) posted its quarterly earnings data on Wednesday, August, 14th. The company reported ($1.15) EPS for the quarter, topping the consensus estimate of ($2.30) by $1.15.

Shares of AlloVir reverse split before market open on Thursday, January 16th 2025. The 1-23 reverse split was announced on Wednesday, January 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, January 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

AlloVir (ALVR) raised $252 million in an IPO on Thursday, July 30th 2020. The company issued 14,800,000 shares at $16.00-$18.00 per share. Morgan Stanley, J.P. Morgan, SVB Leerink and Piper Sandler acted as the underwriters for the IPO.

Shares of ALVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AlloVir investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), AUO (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/14/2024
Today
5/27/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALVR
Fax
N/A
Employees
110
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$190.42 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$29.35 per share
Price / Book
0.10

Miscellaneous

Free Float
3,425,000
Market Cap
$14.07 million
Optionable
Optionable
Beta
0.63
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ALVR) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners